Mednet Logo
HomeEndocrinologyQuestion

Following oral cavity radiotherapy, how do you advise patients on ongoing bisphosphonate therapy and the risk for osteonecrosis?

2
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Weatherby Health Care

I asked the question, but since no one has responded, I will just comment that I have discontinued such therapy in one of my H&N patients for fear of increasing the odds of osteonecrosis occurring.

Register or Sign In to see full answer

Following oral cavity radiotherapy, how do you advise patients on ongoing bisphosphonate therapy and the risk for osteonecrosis? | Mednet